首頁 > 市場調查報告書 > 醫療設備

醫學影像診斷

市場調查報告書

商品編碼

1625016

全球診斷影像市場規模（按產品、最終用戶、地區、範圍和預測）

Global Diagnostic Imaging Market Size By Product (Ultrasound Imaging Systems, X-Ray Imaging Systems), By End User (Hospitals, Diagnostic Imaging Centers), By Geographic Scope And Forecast

出版日期: 2024年10月25日 | 出版商:

Verified Market Research | 英文 202 Pages | 商品交期: 2-3個工作天內

價格

簡介目錄

診斷影像的市場規模與預測

2021 年診斷影像市場規模價值為 261 億美元，預計到 2030 年將達到 399 億美元，2022 年至 2030 年的複合年增長率為 5.4%。診斷影像包括多種觀察人體以診斷、監測和治療疾病的技術。每種技術提供有關正在研究或治療的身體部位的不同信息，例如疾病、損傷或治療效果。由於老年人口的增長、最新醫學影像技術的使用增加、技術進步、對改進光學成像以實現更好的健康和疾病診斷的需求不斷增長，以及慢性病發病率上升。增加。全球診斷成像市場報告對市場進行了全面的評估。它對關鍵細分市場、趨勢、市場推動因素、阻礙因素、競爭格局以及在市場中發揮關鍵作用的因素進行了全面的分析。

定義全球診斷影像市場

對身體內部結構進行成像以進行診斷或治療的非侵入性方法稱為診斷影像或醫學影像。最新的是X光、磁振造影（MRI）、電腦斷層掃瞄（CT）、產前檢查和其他診斷影像方式。護理人員將進行影像學測試以做出正確的診斷和檢查。此外，該技術也被用於密切監測患者身體對治療和藥物的反應。診斷影像是指用於觀察身體內部以識別和查明健康問題或狀況的原因的多種程序。

醫師也會評估您的身體對骨折或疾病治療的反應。透過影像學檢查，醫生可以看到您的身體內部，並瞭解是否有任何不健康的跡象。一些設備和程式可以產生身體活動和結構的圖像。您的醫生可能會確定需要進行影像學檢查來支持所檢查的區域或症狀。影像測試使用強力磁鐵、無線電波和筆記型電腦來提供身體內部器官和結構的詳細橫截面圖片。掃瞄器就像一根長管，中間有一張桌子，病人可以滑到桌子上。

影像掃瞄使用強力磁鐵、無線電波和電腦來提供內部器官和結構的詳細橫截面圖片。掃瞄器通常位於一根細長的管子內，中間有一張桌子，病人可以滑到桌子上。 MRI 掃瞄與 CT 掃瞄或 X 光不同。因此，它不使用任何危險的輻射。影像掃瞄的誕生標誌著醫學史上的一個分水嶺。醫生、科學家和研究人員現在使用非侵入性設備來詳細檢查身體內部。

醫療專業人員使用電腦斷層掃瞄（通常是 CT 掃瞄）來研究身體內部結構。 CT 掃瞄使用 X 光和電腦來形成身體橫斷面的圖片。它會獲取骨骼、肌肉、器官和血管的微小 "像素" ，讓醫療專業人員能夠詳細檢查您的身體。舊式X射線機是使用堅硬、快速的管子將X射線傳送到選定位置的X射線機。當 X 射線穿過人體時，不同的組織會吸收不同量的 X 射線。與不同的組織相比，緻密的組織在膠卷的黑色背景上能提供更白的影像。

全球診斷影像市場概覽

老年人口的不斷成長推動了這個市場的發展。隨著醫療設備變得越來越普及，基於影像的診斷變得越來越普遍。複雜和慢性疾病的發生率不斷上升，推動了診斷影像市場的需求。政府和產業的支持與投資為採用成像技術進行更好的診斷和治療奠定了基礎。隨著年齡的增長，患病的風險也會增加。根據美國疾病管制中心（CDC）的數據，美國約有 80% 的老年人患有至少一種慢性疾病。

此外，美國醫學協會（AMA）預計，65歲以上人口中患有多種慢性病的比例將達到至少60%。隨著人口老化，對更昂貴的療養院、新穎的治療方案和處方藥的需求可能會更大。隨著世界老年人口的增長，預計阿茲海默症、腦部疾病、關節炎和失智症等與年齡相關的疾病以及癌症的盛行率將會上升。新冠肺炎疫情對市場既產生了正面影響，也產生了負面影響。醫院，尤其是小型醫院和影像中心的購買力相對下降。

製造業也受到了疫情的影響。此外，現行的包裝標準和國家強制的異議程序也影響了產品和維修的交付時間。所有這些問題都影響著診斷成像系統的生產和供應鏈。由於醫院需要釋放容量和資源來應對未來的新冠肺炎病例，常規和選擇性手術的頻率顯著減少。因此，此次疫情為診斷成像產業帶來了沉重打擊。然而，這種下降可能只會產生短期的負面影響，對長期推動診斷影像設備需求的因素影響不大。

任何單一影像方式的一般技術限制使得研究人員難以取得並限制市場擴張。例如，MRI需要時間來掃瞄大量高品質影像，但PET的空間解析度較低。操作者嚴重依賴超音波設備，而超音波設備需要與身體直接接觸，組織穿透深度有限。 SPECT檢測靈敏度低，CT軟組織對比低。結果，關於結果品質的資訊很少，醫生和患者都暴露在輻射下。然而，這種成像技術價格昂貴，設備成本可能成為發展中國家的一個主要障礙。

Diagnostic Imaging Market size was valued at USD 26.1 Billion in 2021 and is projected to reach USD 39.9 Billion by 2030, growing at a CAGR of 5.4% from 2022 to 2030. Diagnostic imaging comprises a variety of techniques for seeing the human body to diagnose, monitor, or treat medical disorders. Each type of technology provides various information on the body part being investigated or treated, such as sickness, injury, or the efficacy of medical treatment. The Global Diagnostic Imaging Market is expanding due to an increase in the geriatric population, greater usage of modern medical imaging technology, technological advancements, a rising need for improved optical imaging for better health and disease diagnosis, and a surge in the incidence of chronic disorders. The Global Diagnostic Imaging Market report provides a holistic evaluation of the market. The report offers a comprehensive analysis of key segments, trends, drivers, restraints, competitive landscape, and factors that are playing a substantial role in the market.

Global Diagnostic Imaging Market Definition

Non-invasive methods of making pictures of within body structures for diagnostic and therapeutic reasons look named diagnostic or medical imaging. The most current are X-rays, resonance imaging (MRI), CT (CT), prenatal diagnosis, and different diagnostic imaging methods. Care staff uses diagnostic imaging to create correct diagnoses and examinations. Additionally, the technology is employed to rigorously monitor the patient's body's response to the treatment and drugs. Diagnostic imaging refers to numerous procedures for looking into the body to see the source of a health problem or harm and ensure a designation.

Doctors additionally assess how well a patient's body responds to fracture or illness medical care. Diagnostic imaging permits doctors to see within the body to envision whether or not there are any signs of ill health. Some devices and procedures generate pictures of your body's activities and structures. The doctor can determine that medical imaging tests are needed to support the examined piece and the symptoms. AN imaging scan provides an in-depth cross-sectional image of inner organs and structures employing a powerful magnet, radio waves, and a laptop. The scanner is often within the kind of a long tube with a table within the center wherever the patient will slide.

An imaging scan provides a detailed cross-sectional image of inner organs and structures employing a powerful magnet, radio waves, and a computer. The scanner is commonly within an elongated tube with a table within the center wherever the patient will slide. An MRI scan varies from CT scans and X-rays. As a result, it doesn't use radiation, which may be dangerous. The creation of the imaging scan is a watershed moment in medical history. Doctors, scientists, and researchers will currently use non-invasive instrumentation to examine the within of the flesh in excellent detail.

Medical practitioners use computed tomography to research structures within your body, usually CT scans. A CT scan uses X-rays and computers to form pictures of a crosswise of your body. It takes photos of your bones, muscles, organs, and blood vessels in little "pixels," so care professionals will examine your body in excellent detail. Old X-ray machines are X-ray devices that use a hard and fast tube to direct X-rays to a selected location. X-rays different absorbed in varying amounts by totally different tissues as they pass through the body. Higher-density tissue provides a whiter image on the black background of the film than different tissues.

What's inside a VMR industry report?

Our reports include actionable data and forward-looking analysis that help you craft pitches, create business plans, build presentations and write proposals.

Global Diagnostic Imaging Market Overview

The growing geriatric population has driven the trade. Imaging-based diagnosis has become more common as medical instrumentality has been readily offered. The rising frequency of complicated and chronic diseases has increased the market's demand for diagnostic imaging. Government and sector support and investments have aided the adoption of diagnostic imaging for better diagnosing and treatment. With age, the danger of developing diseases rises correspondingly. In keeping to the Centers for disease control and bar, about 80th of the aged in the United States suffer from at least one chronic condition (CDC).

Furthermore, the American Medical Association (AMA) expects a minimum of 60 minutes for people aged 65 and up to have several chronic conditions. Because the population ages, there'll be a more significant demand for higher care facilities, novel treatment choices, and prescribed drugs. The prevalence of age-related disorders like Alzheimer's disease, brain disease, arthritis, and dementia, similar to disorders and cancer, is foretold to rise because the global geriatric population is growing. The pandemic of COVID-19 has had both positive and harmful effects on the market. The buying power of hospitals, notably small-scale hospitals and imaging centers, is relatively forced.

Manufacturing firms have also been suffering from the pandemic. Moreover, product and repair delivery turnaround times are hindered because of current packaging standards and country-imposed opposition processes. All of those issues hurt diagnostic imaging system production and provide chains. As hospitals were required to release capability and resources for future COVID-19, the frequency of regular and elective procedures decreased significantly. As a result, the pandemic harmed the diagnostic imaging trade. This decline, however, is only probably to possess a short-run negative impact on the trade, with very little or no change within the long-run elemental forces driving diagnostic imaging device demand.

Due to the general technological restrictions related to solitary imaging modalities, researchers are hesitant to get them, limiting their market expansion. For instance, MRI takes longer to scan massive volumes of high-quality pictures; however, PET has a lesser spatial resolution. The operator depends heavily on ultrasound equipment, which needs direct contact with the body and has a restricted tissue penetration depth. SPECT has low detection sensitivity, and CT has poor soft-tissue contrast. Therefore, it provides less info regarding purposeful qualities and exposes doctors and patients to radiation. However, such imaging techniques come at a high cost, and the equipment's price may be a significant hurdle in developing countries.

Global Diagnostic Imaging Market: Segmentation Analysis

The Global Diagnostic Imaging Market is Segmented on the basis of Product, End User, And Geography.

Diagnostic Imaging Market, By Product

Magnetic Resonance Imaging (MRI) Systems
Computed Tomography (CT) Scanners
Ultrasound Imaging Systems
X-Ray Imaging Systems
Others

Based on Product, The market is segmented into Magnetic Resonance Imaging (MRI) Systems, Computed Tomography (CT) Scanners, Ultrasound Imaging Systems, X-Ray Imaging Systems, and Others. The X-ray Imaging system category is predicted to increase the most during the forecast period, owing to the rising occurrence of orthopedic injuries and accidents, as well as the growing need for point-of-care testing, which is boosting the sale of portable equipment.

The CT scanners category accounted for the largest share of the worldwide Diagnostic Imaging Market in 2020. The increasing demand for early and precise diagnosis, as well as the widespread usage of CT scanners by hospitals and diagnostic centers worldwide, can be attributed to the high expansion of this product category. Demand for CT scanners has gradually increased since the onset of the COVID-19 outbreak.

Diagnostic Imaging Market, By End User

Hospitals
Diagnostic Imaging Centers

Based on End User, The market is segmented into Hospitals and Diagnostic Imaging Centers. The hospital segment is forecasted to expand during the projected period due to increased awareness regarding health and an increased number of patients with Chronic diseases coming for treatment to the hospital.

Diagnostic Imaging Market, By Geography

North America
Europe
Asia Pacific
Rest of the world
On the basis of Geography, The Global Diagnostic Imaging Market is classified into North America, Europe, Asia Pacific, and the Rest of the world. The Diagnostic Imaging Market in the Asia Pacific is predicted to grow at the fastest rate during the forecast period, owing to the growing incidence of chronic illnesses, the increase in the geriatric population, and the increased demand for enhanced imaging technologies. Moreover, an increasing number of local manufacturing units are projected to manufacture lower-priced diagnostic devices, aiding in the region's price-sensitive, underdeveloped market segment.

Key Players

The "Global Diagnostic Imaging Market" study report will provide valuable insight with an emphasis on the global market including some of the major players such as
Koninklijke Philips N.V., Shimadzu Corporation, Siemens Group, Hitachi Medical Systems, Carestream Health Inc., General Electric Company, Hitachi Ltd., Boston Scientific, EsaoteSpA, Canon Inc., Boston Scientific, Samsung Medison, and Fujifilm Holdings Corporation.

Our market analysis also entails a section solely dedicated to such major players wherein our analysts provide an insight into the financial statements of all the major players, along with product benchmarking and SWOT analysis. The competitive landscape section also includes key development strategies, market share, and market ranking analysis of the above-mentioned players globally.

Key Developments

In May 2021, Royal Philips introduced the Spectrum Computed Tomography (CT) 7500, a spectral detector-based CT scanner. This new intelligent technology consistently produces high-quality spectral images for every patient on every scan, helping to enhance disease characterization and reduce rescans and follow-ups while using the same dosage levels as traditional scans.
In April 2021, the device "single-source Nanox ARC digital X-ray technology" manufactured by NANO-X IMAGING was approved by the US Food and Drug Administration (FDA).
In May 2020, RADLogics announced that it will be offering software to the nuance AL Marketplace. So, COVID-19 was detected using artificial intelligence-powered medical imaging apps.
In May 2020, Life Image launched the Patient Connect Portal to give patients control over their longitudinal imaging records and medical data, which they can share with care providers.
In February 2019, the EPIQ Elite ultrasound system was launched by Koninklijke Philips N.V., the Netherlands, for general imaging and obstetrics and gynecological applications.

1 INTRODUCTION OF GLOBAL DIAGNOSTIC IMAGING MARKET

1.1 Overview of the Market
1.2 Scope of Report
1.3 Assumptions

2 EXECUTIVE SUMMARY

3 RESEARCH METHODOLOGY OF VERIFIED MARKET RESEARCH

3.1 Data Mining
3.2 Validation
3.3 Primary Interviews
3.4 List of Data Sources

4 GLOBAL DIAGNOSTIC IMAGING MARKET OUTLOOK

4.1 Overview
4.2 Market Dynamics
- 4.2.1 Drivers
- 4.2.2 Restraints
- 4.2.3 Opportunities
4.3 Porters Five Force Model
4.4 Value Chain Analysis

5 GLOBAL DIAGNOSTIC IMAGING MARKET, BY PRODUCT

5.1 Overview
5.2 Magnetic Resonance Imaging (MRI) Systems
5.3 Computed Tomography (CT) Scanners
5.4 Ultrasound Imaging Systems
5.5 X-Ray Imaging Systems
5.6 Others

6 GLOBAL DIAGNOSTIC IMAGING MARKET, BY END USER

6.1 Overview
6.2 Hospitals
6.3 Diagnostic Imaging Centers

7 GLOBAL DIAGNOSTIC IMAGING MARKET, BY GEOGRAPHY

7.1 Overview
7.2 North America
- 7.2.1 U.S.
- 7.2.2 Canada
- 7.2.3 Mexico
7.3 Europe
- 7.3.1 Germany
- 7.3.2 U.K.
- 7.3.3 France
- 7.3.4 Rest of Europe
7.4 Asia Pacific
- 7.4.1 China
- 7.4.2 Japan
- 7.4.3 India
- 7.4.4 Rest of Asia Pacific
7.5 Rest of the World
- 7.5.1 Latin America
- 7.5.2 Middle East and Africa

8 GLOBAL DIAGNOSTIC IMAGING MARKET COMPETITIVE LANDSCAPE

8.1 Overview
8.2 Company Market Ranking
8.3 Key Development Strategies

9 COMPANY PROFILES

9.1 Koninklijke Philips N.V.
- 9.1.1 Overview
- 9.1.2 Financial Performance
- 9.1.3 Product Outlook
- 9.1.4 Key Developments
9.2 Shimadzu Corporation
- 9.2.1 Overview
- 9.2.2 Financial Performance
- 9.2.3 Product Outlook
- 9.2.4 Key Developments
9.3 Siemens Group
- 9.3.1 Overview
- 9.3.2 Financial Performance
- 9.3.3 Product Outlook
- 9.3.4 Key Developments
9.4 Hitachi Medical Systems
- 9.4.1 Overview
- 9.4.2 Financial Performance
- 9.4.3 Product Outlook
- 9.4.4 Key Developments
9.5 Carestream Health Inc.
- 9.5.1 Overview
- 9.5.2 Financial Performance
- 9.5.3 Product Outlook
- 9.5.4 Key Developments
9.6 General Electric Company
- 9.6.1 Overview
- 9.6.2 Financial Performance
- 9.6.3 Product Outlook
- 9.6.4 Key Developments
9.7 Hitachi Ltd.
- 9.7.1 Overview
- 9.7.2 Financial Performance
- 9.7.3 Product Outlook
- 9.7.4 Key Developments
9.8 Boston Scientific
- 9.8.1 Overview
- 9.8.2 Financial Performance
- 9.8.3 Product Outlook
- 9.8.4 Key Developments
9.9 EsaoteSpA
- 9.9.1 Overview
- 9.9.2 Financial Performance
- 9.9.3 Product Outlook
- 9.9.4 Key Developments
9.10 Canon Inc.
- 9.10.1 Overview
- 9.10.2 Financial Performance
- 9.10.3 Product Outlook
- 9.10.4 Key Developments
9.11 Samsung Medison
- 9.11.1 Overview
- 9.11.2 Financial Performance
- 9.11.3 Product Outlook
- 9.11.4 Key Developments
9.12 Fujifilm Holding Corporation
- 9.12.1 Overview
- 9.12.2 Financial Performance
- 9.12.3 Product Outlook
- 9.12.4 Key Developments